KPRX Company Profile and Key Details

Q: Who are the executives of KPRX?

Dr. Stefan Sperl Ph.D.Executive Vice President of CMC & OperationsDr. Eric J. Daniels M.B.A., M.D.Chief Devel. OfficerMs. Melissa ToscaExecutive Vice President of Fin.Dr. MaryJane Rafii Ph.D.ConsultantDr. Brian M. Strem Ph.D.Pres, Chief Executive Officer & DirectorMs. Melissa Tosca C.P.A.Executive Vice President of Fin.Ms. Melissa Tosca CPAExecutive Vice President of Fin.

NASDAQ : KPRX

Kiora Pharmaceuticals

$2.60

-0.08-2.99%

Open: 3:20 PM

75.83

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kiora Pharmaceuticals, Inc. (KPRX) stock declined over -2.99%, trading at $2.60 on NASDAQ, down from the previous close of $2.68. The stock opened at $2.63, fluctuating between $2.60 and $2.70 in the recent session.

Stock Snapshot

2.68

Prev. Close

11.52M

Market Cap

2.6

Day Low

-0.96

P/E Ratio

-2.7

EPS (TTM)

-1.24

Cash Flow per Share

2.63

Open

4.43M

Number of Shares

2.6952

Day High

85.32%

Free Float in %

0.79

Book Value

8.28K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 21, 2026	2.60	2.70	2.59	2.68	19.33K
May 20, 2026	2.53	2.70	2.53	2.64	44.22K
May 19, 2026	2.50	2.54	2.47	2.52	34.26K
May 18, 2026	2.51	2.55	2.49	2.51	16.91K
May 15, 2026	2.57	2.60	2.50	2.50	31.09K
May 14, 2026	2.69	2.72	2.52	2.58	257.9K
May 13, 2026	2.42	2.71	2.42	2.69	90.69K
May 12, 2026	2.43	2.52	2.41	2.44	21.74K
May 11, 2026	2.50	2.58	2.40	2.41	39.46K
May 08, 2026	2.71	2.71	2.40	2.45	40.83K
May 07, 2026	2.51	2.55	2.35	2.45	151.87K
May 06, 2026	2.49	2.57	2.44	2.51	25.29K
May 05, 2026	2.56	2.62	2.46	2.51	22.54K
May 04, 2026	2.45	2.60	2.41	2.54	59.5K
Apr 30, 2026	2.34	2.38	2.31	2.35	39.35K
Apr 29, 2026	2.37	2.37	2.29	2.35	23.9K
Apr 28, 2026	2.33	2.47	2.31	2.33	65.6K
Apr 27, 2026	2.35	2.41	2.30	2.32	30.61K
Apr 23, 2026	2.45	2.45	2.39	2.40	16.59K
Apr 22, 2026	2.49	2.50	2.42	2.44	13.66K

Contact Details

Encinitas, UT 84105

United States

https://www.kiorapharma.com 781 788 8869

About Company

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

Stock Peers

ARGX

11.97+1.49%

argenx SE$816.22 REGN

-7.17-1.10%

Regeneron Pharmaceuticals, Inc.$642.59 UTHR

1.94+0.34%

United Therapeutics Corporation$565.87 MDGL

0.12+0.02%

Madrigal Pharmaceuticals, Inc.$513.59 VRTX

3.1+0.72%

Vertex Pharmaceuticals Incorporated$433.54 PRAX

14.95+4.45%

Praxis Precision Medicines, Inc.$350.56 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.18+0.72%

Krystal Biotech, Inc.$304.23 ALNY

2.03+0.68%

Alnylam Pharmaceuticals, Inc.$300.51 ASND

6.17+2.56%

Ascendis Pharma A/S$247.51

Frequently Asked Questions

What is the current Kiora Pharmaceuticals, Inc. (KPRX) stock price?

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) stock price is $2.60 in the last trading session. During the trading session, KPRX stock reached the peak price of $2.70 while $2.60 was the lowest point it dropped to. The percentage change in KPRX stock occurred in the recent session was -2.99% while the dollar amount for the price change in KPRX stock was - $0.08.

KPRX's industry and sector of operation?

The NASDAQ listed KPRX is part of Biotechnology industry that operates in the broader Healthcare sector. Kiora Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KPRX?

Dr. Stefan Sperl Ph.D.
Executive Vice President of CMC & Operations
Dr. Eric J. Daniels M.B.A., M.D.
Chief Devel. Officer
Ms. Melissa Tosca
Executive Vice President of Fin.
Dr. MaryJane Rafii Ph.D.
Consultant
Dr. Brian M. Strem Ph.D.
Pres, Chief Executive Officer & Director
Ms. Melissa Tosca C.P.A.
Executive Vice President of Fin.
Ms. Melissa Tosca CPA
Executive Vice President of Fin.

How KPRX did perform over past 52-week?

KPRX's closing price is 51.84% higher than its 52-week low of $1.77 where as its distance from 52-week high of $4.18 is -35.88%.

How many employees does KPRX have?

Number of KPRX employees currently stands at 12.

Link for KPRX official website?

Official Website of KPRX is: https://www.kiorapharma.com

How do I contact KPRX?

KPRX could be contacted at phone 781 788 8869 and can also be accessed through its website. KPRX operates from 1371 East 2100 South, Encinitas, UT 84105, United States.

How many shares of KPRX are traded daily?

KPRX stock volume for the day was 8.28K shares. The average number of KPRX shares traded daily for last 3 months was 489.81K.

What is the market cap of KPRX currently?

The market value of KPRX currently stands at $11.52M with its latest stock price at $2.60 and 4.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	12
Beta	-0.77
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	12
Beta	-0.77
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KPRX Company Profile and Key Details

Kiora Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook